E-DRUG: WHO prequalifies another 10 ARVs
----------------------------------------
WHO has announced that 10 more ARVs were included on the list of prequalified products; 7 from Ranbaxy, and 3 from Aurobindo.
Important is also that a FDC is again included.
288 Lamivudine 150mg Tablets Aurobindo Pharma Ltd HDPE Bottle 60
289 Lamivudine 300mg Tablets Aurobindo Pharma Ltd HDPE Bottle 60
290 Lamivudine 150mg Tablets Ranbaxy Laboratories Limited HDPE bottle 60 Blister 10
301 Lamivudine/Stavudine 150mg/40mg Tablets Ranbaxy Laboratories Limited HDPE bottle 60 Blister 10
302 Lamivudine/Stavudine 150mg/30mg Tablets Ranbaxy Laboratories Limited HDPE bottle 60 Blister 10
299 Lamivudine/Stavudine/Nevirapine 150mg/40mg/200mg Tablets Ranbaxy Laboratories Limited HDPE bottle 60
300 Lamivudine/Stavudine/Nevirapine 150mg/30mg/200mg Tablets Ranbaxy Laboratories Limited HDPE bottle 60
286 Lamivudine/Zidovudine 150mg/300mg Tablets Ranbaxy Laboratories Limited HDPE bottle 60
294 Zidovudine 300mg Tablets Ranbaxy Laboratories Limited HDPE bottle 60 Blister 10
285 Zidovudine 300mg Tablets Aurobindo Pharma Ltd HDPE Bottle 60
For further details, please see the WHO PQ website (http://mednet3.who.int/prequal/).
---------
Wilbert Bannenberg, E-drug moderator
Email: wjb@planet.nl
The 1995-2004 E-drug archives are at http://www.essentialdrugs.org/edrug/
(un)Subscribe E-drug at:
http://list.healthnet.org/mailman/listinfo/e-drug